[go: up one dir, main page]

HN2002000112A - Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma. - Google Patents

Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.

Info

Publication number
HN2002000112A
HN2002000112A HN2002000112A HN2002000112A HN2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A HN 2002000112 A HN2002000112 A HN 2002000112A
Authority
HN
Honduras
Prior art keywords
triazatetraciclo
pentaene
hexadeca
same
pharmaceutical compositions
Prior art date
Application number
HN2002000112A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to HN2002000112A priority Critical patent/HN2002000112A/es
Publication of HN2002000112A publication Critical patent/HN2002000112A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A LA SAL CITRATO DE 5, 8, 14 - TRIAZATETRACICLO [10.3.1.02,11.04,9] - HEXADECA - 2 (11), 3,5,7,9 - PENTAENO.
HN2002000112A 2002-05-08 2002-05-08 Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma. HN2002000112A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000112A HN2002000112A (es) 2002-05-08 2002-05-08 Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000112A HN2002000112A (es) 2002-05-08 2002-05-08 Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.

Publications (1)

Publication Number Publication Date
HN2002000112A true HN2002000112A (es) 2002-07-04

Family

ID=53189406

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000112A HN2002000112A (es) 2002-05-08 2002-05-08 Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.

Country Status (1)

Country Link
HN (1) HN2002000112A (es)

Similar Documents

Publication Publication Date Title
UA96449C2 (en) Stable laquinimod preparations
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
SE0001899D0 (sv) New compounds
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1111867T1 (el) Ενωση ενεργοποιησης ppar και φαρμακευτικη συνθεση που περιεχει αυτη
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ECSP034850A (es) Sal citrato de 5, 8, 14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
IS6956A (is) Sítrat salt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9-pentaen og lyfjafræðilegar samsetningar af því
BRPI0417950A (pt) composições farmacêuticas
DE602004028448D1 (de) Orale zubereitungen enthaltend cladribin
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
YU87501A (sh) Farmaceutski kompleksi
HN2002000112A (es) Sal citrato de 5, 8,14 - triazatetraciclo [10.3.1.02.11.04.9] - hexadeca - 2 (11),3,5,7,9 - pentaeno y composiciones farmaceuticas de la misma.
PL403800A1 (pl) Kompozycja farmaceutyczna
PT1358159E (pt) Tartrato e fosfato de 3,4 diaminopiridina, as suas composições farmacêuticas e as suas utilizações
HN2000000076A (es) Polimorfos de un citrato de azobiciclo (2,2,2) oct-3 -ilamina cristalino y sus composiciones farmaceuticas.